Interest of Impedancemetry in Monitoring Hydration and Hyponatremia During Subarachnoid Hemorrhages
Recruiting
Observational Study
Subarachnoid Hemorrhage (SAH)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Hospices Civils de Lyon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Subarachnoid hemorrhage (SAH) is a rare and serious form of stroke, mainly linked to the rupture of an intracranial aneurysm responsible for bleeding into the meningeal spaces.
The main late serious complication is delayed cerebral ischemia (DCI), resulting in the appearance of new neurological deficits.
Prevention of ICR involves in particular maintaining euvolemia, and early treatment of hypon…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult man, woman
* Hospitalized following Subarachnoid Hemorrhage within 72 hours of bleeding
* Admitted to the neurological intensive care unit for less than 48 hours
* Being able to understand the ins and outs of the study
* Having expressed his non-opposition
Exclusion Cri…
Contacts